Nebulisers ruled out for bronchiolitis in children

GPs should not use nebulisers in the treatment of bronchiolitis in children, according to guidance from SIGN.

This is the first clinical guidance of its kind in the UK. It was issued in preparation for the winter months where there is a peak prevalence of bronchiolitis.

Despite 2 per cent of all UK infants being admitted to hospital with bronchiolitis, no guidelines have been made available for treatment until now.

The SIGN guidance states that nebulised ribavirin, nebulised ipratropium and nebulised epinephrine should not be used for the treatment of infants with acute bronchiolitis. Antibiotic therapy and inhaled beta 2 agonist bronchodilators are not recommended for treatment either.

The routine use of palivizumab is not recommended but may be considered for use on a case-by-case basis in infants, less than 12 months old, with extreme prematurity or immune deficiency.

Somerset GP Dr Steve Holmes, chairman of the General Practice Airways Group, said: 'It is nice to see a review of the bronchiolitis literature that clears up the issues of whether to use nebulisers for the treatment of bronchiolitis.'

Consultant respiratory paediatrician Dr Steve Cunningham, chairman of the SIGN bronchiolitis guideline group, said that the guidelines would provide the latest evidence-driven guidance that GPs could use.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:


Just published

NHS prescription and packet of pills

GPs can now prescribe flu antivirals on the NHS

GPs and other prescribers are now able to issue NHS prescriptions for antivirals...

GP sign

Prevention set to be key battleground for 2024 GP contract

Negotiations on a new GP contract from 2024/25 will need to 'align closely' with...

Talking General Practice logo

Podcast: What makes a strong PCN and how will integrated care systems affect networks?

Talking General Practice speaks to GP and PCN clinical director Professor Aruna Garcea,...

Money

GP core funding rise outstripped by staff pay awards under five-year contract

Staff pay awards have outstripped increases in core GP practice funding between 2019/20...

BMA sign

Fifth of GP time spent on non-medical work as NHS absorbs cost of 'government failure'

Doctors are 'picking up the pieces of government failures' as the cost-of-living...

COPD

How the five fundamentals of COPD care can help GPs support patients

GP Dr Andrew Whittamore, clinical lead at Asthma + Lung UK, explains NICE’s five...